Vascular Solutions (NASDAQ: VASC) reported Q1 EPS of $0.25, $0.02 better than the analyst estimate of $0.23. Revenue for the quarter came in at $39 million versus the consensus estimate of $38.37 million.

GUIDANCE:

Vascular Solutions sees Q2 2016 EPS of $0.29-$0.31, versus the consensus of $0.31. Vascular Solutions sees Q2 2016 revenue of $40.5-41.5 million, versus the consensus of $41.3 million.

Vascular Solutions sees FY2016 EPS of $1.19-$1.23, versus prior guidance of $1.17-$1.21 and the consensus of $1.18. Vascular Solutions sees FY2016 revenue of $163-166 million, versus prior guidance of $161-165 million and the consensus of $162.8 million.

For earnings history and earnings-related data on Vascular Solutions (VASC) click here.